All Stories

  1. Poised for Innovation

    Article • Journal of the American Society of Nephrology, August 2024, Wolters Kluwer Health

    Roslyn Mannon

  2. Steroid–tacrolimus drug–drug interaction and the effect of CYP3A genotypes

    Article • British Journal of Clinical Pharmacology, July 2024, Wiley

    Roslyn Mannon

  3. No Time for Cancel Culture

    Article • Journal of the American Society of Nephrology, June 2024, Wolters Kluwer Health

    Roslyn Mannon

  4. The prevalence of postacute sequelae of coronavirus disease 2019 in solid organ transplant recipients: Evaluation of risk in the National COVID Cohort Collaborative

    Article • American Journal of Transplantation, June 2024, Elsevier

    Roslyn Mannon

  5. Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival

    Article • American Journal of Transplantation, April 2024, Elsevier

    Roslyn Mannon

  6. Prospective observational study to validate a next-generation sequencing blood RNA signature to predict early kidney transplant rejection

    Article • American Journal of Transplantation, March 2024, Elsevier

    Roslyn Mannon

  7. The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics

    Article • American Journal of Transplantation, March 2024, Elsevier

    Roslyn Mannon

  8. The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts

    Article • American Journal of Transplantation, March 2024, Elsevier

    Roslyn Mannon

  9. The Banff process—Reloaded: A joint initiative from the Banff Foundation for Allograft Pathology and the American Journal of Transplantation

    Article • American Journal of Transplantation, March 2024, Elsevier

    Roslyn Mannon

  10. Impact of Centers for Medicare and Medicaid Services Final Rule on Organ Procurement Organization Metrics and Procedural Trends in the Procurement of Pancreata for Research

    Article • Pancreas, January 2024, Wolters Kluwer Health

    Roslyn Mannon

  11. Personalizing kidney transplant donor-specific antibody surveillance: The devil is in the details

    Article • American Journal of Transplantation, December 2023, Elsevier

    Roslyn Mannon

  12. Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population

    Article • American Journal of Transplantation, July 2023, Elsevier

    Roslyn Mannon

  13. Kidney Transplant Practice in Pandemic Times

    Article • Clinical Journal of the American Society of Nephrology, January 2023, Wolters Kluwer Health

    Roslyn Mannon

  14. Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers

    Article • Clinical Transplantation, January 2023, Wiley

    Roslyn Mannon

  15. The Gut Microbiome Links to Metabolic Syndrome Following Kidney Transplantation

    Article • Journal of the American Society of Nephrology, November 2022, Wolters Kluwer Health

    Roslyn Mannon

  16. The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls

    Article • American Journal of Transplantation, October 2022, Elsevier

    Roslyn Mannon

  17. A multi-faceted approach to sex and gender equity in solid organ transplantation: The Women in Transplantation Initiative of The Transplantation Society

    Article • Frontiers in Immunology, September 2022, Frontiers

    Roslyn Mannon

  18. Impact of CYP3A5 Status on the Clinical and Financial Outcomes Among African American Kidney Transplant Recipients

    Article • Transplantation Direct, September 2022, Wolters Kluwer Health

    Roslyn Mannon

  19. Data carve out in the midst of the COVID ‐19 pandemic

    Article • American Journal of Transplantation, July 2022, Wiley

    Roslyn Mannon

  20. Exacerbation of Racial Disparities in Living Donor Kidney Transplantation During the COVID-19 Pandemic

    Article • Kidney360, June 2022, Wolters Kluwer Health

    Roslyn Mannon

  21. Deceased Donor Procurement Biopsy Practices, Interpretation, and Histology-Based Decision-Making: A Survey of US Kidney Transplant Centers

    Article • Kidney International Reports, June 2022, Elsevier

    Roslyn Mannon

  22. The Agony and the Ecstasy: Stories from Organ Transplant Recipients

    Article • Narrative Inquiry in Bioethics, June 2022, Project Muse

    Roslyn Mannon

  23. Abnormal time‐zero histology is predictive of kidney transplant outcomes

    Article • Clinical Transplantation, April 2022, Wiley

    Roslyn Mannon

  24. Premature Death in Kidney Transplant Recipients: The Time for Trials is Now

    Article • Journal of the American Society of Nephrology, March 2022, American Society of Nephrology

    Roslyn Mannon

  25. T cell–mediated rejection in kidney transplant recipients: The end(point) is also the beginning

    Article • American Journal of Transplantation, March 2022, Elsevier

    Roslyn Mannon

  26. From the Cradle to the Grave: The Life Cycle of Gender Disparities in Kidney Care

    Article • Kidney International Reports, March 2022, Elsevier

    Roslyn Mannon

  27. Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation

    Article • Cochrane Database of Systematic Reviews, February 2022, Wiley

    Roslyn Mannon

  28. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

    Article • JAMA Internal Medicine, February 2022, American Medical Association (AMA)

    Roslyn Mannon

  29. Understanding and Overcoming Financial Risks for Living Organ Donors

    Article • American Journal of Kidney Diseases, February 2022, Elsevier

    Roslyn Mannon

  30. Risk Prediction for Delayed Allograft Function: Analysis of the Deterioration of Kidney Allograft Function (DeKAF) Study Data

    Article • Transplantation, January 2022, Wolters Kluwer Health

    Roslyn Mannon

  31. Gut microbial biomarkers for predicting adverse outcomes in people with chronic kidney disease

    Article • Cochrane Database of Systematic Reviews, January 2022, Wiley

    Roslyn Mannon

  32. Disparities in Access to Preemptive Repeat Kidney Transplant: Still Missing the Mark?

    Article • Kidney360, January 2022, Wolters Kluwer Health

    Roslyn Mannon

  33. Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative

    Article • The Lancet Rheumatology, January 2022, Elsevier

    Roslyn Mannon

  34. Roslyn (“Roz”) Bernstein Mannon, MD

    Article • Transplantation, December 2021, Wolters Kluwer Health

    Roslyn Mannon

  35. Emerging biomarkers in kidney transplantation and challenge of clinical implementation

    Article • Current Opinion in Organ Transplantation, November 2021, Wolters Kluwer Health

    Roslyn Mannon

  36. Sex and organ‐specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID‐19

    Article • American Journal of Transplantation, November 2021, Wiley

    Roslyn Mannon

  37. Operational challenges in the COVID‐19 era: Asymptomatic infections and vaccination timing

    Article • Clinical Transplantation, November 2021, Wiley

    Roslyn Mannon

  38. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

    Article • The Lancet HIV, November 2021, Elsevier

    Roslyn Mannon

  39. Significance of HLA-DQ in kidney transplantation: time to reevaluate human leukocyte antigen–matching priorities to improve transplant outcomes? An expert review and recommendations

    Article • Kidney International, November 2021, Elsevier

    Roslyn Mannon

  40. COVID-19 in Solid Organ Transplantation: Results of the National COVID Cohort Collaborative

    Article • Transplantation Direct, October 2021, Wolters Kluwer Health

    Roslyn Mannon

  41. Time for increased awareness of sex as a biological variable in transplantation

    Article • American Journal of Transplantation, October 2021, Elsevier

    Roslyn Mannon

  42. Incorporation of Sex and Gender Guidelines Into Transplantation Literature

    Article • Transplantation, September 2021, Wolters Kluwer Health

    Roslyn Mannon

  43. Bioenergetic maladaptation and release of HMGB1 in calcineurin inhibitor-mediated nephrotoxicity

    Article • American Journal of Transplantation, September 2021, Elsevier

    Roslyn Mannon

  44. In Memoriam: Barbara T Murphy, MB, BAO, BCh (Hon), MRCIP, FRCPI

    Article • Clinical Transplantation, September 2021, Wiley

    Roslyn Mannon

  45. Disparities in Deceased Organ Donor Research Authorization: Experience at One Organ Procurement Organization and Call for National Conversations

    Article • Kidney International Reports, September 2021, Elsevier

    Roslyn Mannon

  46. Meeting Report: First State of the Art Meeting on Gender Disparity in Kidney Transplantation in the Asia-Pacific

    Article • Transplantation, August 2021, Wolters Kluwer Health

    Roslyn Mannon

  47. Novel Phenotypes for Acute Kidney Transplant Rejection Using Semi-supervised Clustering

    Article • Journal of the American Society of Nephrology, August 2021, American Society of Nephrology

    Roslyn Mannon

  48. COVID-19 Disease Severity among People with HIV Infection or Solid Organ Transplant in the United States: A Nationally-representative, Multicenter, Observational Cohort Study

    Article • July 2021, Cold Spring Harbor Laboratory Press

    Roslyn Mannon

  49. Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection

    Article • Journal of the American Society of Nephrology, July 2021, American Society of Nephrology

    Phil Halloran, Roslyn Mannon

  50. Banff and ABMR: Are we going in the right direction?

    Article • American Journal of Transplantation, July 2021, Elsevier

    Roslyn Mannon

  51. Living Organ Donor Perspectives and Sources of Hesitancy about COVID-19 Vaccines

    Article • Kidney360, July 2021, Wolters Kluwer Health

    Roslyn Mannon

  52. A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant

    Article • Kidney International, July 2021, Elsevier

    Roslyn Mannon

  53. Industry partnerships in transplantation: How should AJT manage the inevitable conflict of interest?

    Article • American Journal of Transplantation, May 2021, Elsevier

    Roslyn Mannon

  54. i-IFTA and chronic active T cell–mediated rejection: A tale of 2 (DeKAF) cohorts

    Article • American Journal of Transplantation, May 2021, Elsevier

    Roslyn Mannon

  55. Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic

    Article • American Journal of Kidney Diseases, May 2021, Elsevier

    Roslyn Mannon

  56. Chronic Allograft Injury

    Article • Clinical Journal of the American Society of Nephrology, April 2021, American Society of Nephrology

    Roslyn Mannon, Roslyn Mannon

  57. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts

    Article • Kidney360, April 2021, Wolters Kluwer Health

    Roslyn Mannon

  58. COVID‐19 test result reporting for deceased donors: Emergent policies, logistical challenges, and future directions

    Article • Clinical Transplantation, March 2021, Wiley

    Roslyn Mannon

  59. Sex matters: COVID-19 in kidney transplantation

    Article • Kidney International, March 2021, Elsevier

    Roslyn Mannon

  60. Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry

    Article • The Journal of Clinical Pharmacology, February 2021, Wiley

    Roslyn Mannon

  61. A glossary for patient care and scientific dialogue from KDIGO

    Article • American Journal of Transplantation, February 2021, Elsevier

    Roslyn Mannon

  62. Impact of Subclinical Borderline Inflammation on Kidney Transplant Outcomes

    Article • Transplantation Direct, January 2021, Wolters Kluwer Health

    Roslyn Mannon

  63. Avoidance of CNI and steroids using belatacept—Results of the Clinical Trials in Organ Transplantation 16 trial

    Article • American Journal of Transplantation, December 2020, Elsevier

    Roslyn Mannon

  64. Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real‐life scenario

    Article • Clinical Transplantation, November 2020, Wiley

    Roslyn Mannon

  65. Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 Era

    Article • Kidney International Reports, November 2020, Elsevier

    Roslyn Mannon

  66. Is It Time for Operation Warp Speed in Transplant Research?

    Article • Transplantation Direct, October 2020, Wolters Kluwer Health

    Roslyn Mannon

  67. Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report

    Article • American Journal of Transplantation, October 2020, Elsevier

    Roslyn Mannon

  68. The COVID‐19 pandemic: A community approach

    Article • Clinical Transplantation, September 2020, Wiley

    Roslyn Mannon

  69. Apolipoprotein L1: role in the evaluation of kidney transplant donors

    Article • Current Opinion in Nephrology & Hypertension, September 2020, Wolters Kluwer Health

    Roslyn Mannon

  70. Inflammation in areas of fibrosis: The DeKAF prospective cohort

    Article • American Journal of Transplantation, September 2020, Elsevier

    Roslyn Mannon

  71. The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection

    Article • American Journal of Transplantation, September 2020, Elsevier

    Roslyn Mannon

  72. Pharmacogenomics in kidney transplant recipients and potential for integration into practice

    Article • Journal of Clinical Pharmacy and Therapeutics, July 2020, Hindawi Publishing Corporation

    Roslyn Mannon

  73. Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trial

    Article • American Journal of Transplantation, June 2020, Elsevier

    Roslyn Mannon

  74. The Advancing American Kidney Health (AAKH) Executive Order: Promise and Caveats for Expanding Access to Kidney Transplantation

    Article • Kidney360, June 2020, Wolters Kluwer Health

    Roslyn Mannon

  75. Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report

    Article • American Journal of Transplantation, June 2020, Elsevier

    Roslyn Mannon

  76. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group

    Article • Transplantation, May 2020, Wolters Kluwer Health

    Roslyn Mannon

  77. Use of Checkpoint Inhibitors in a Kidney Transplant Recipient with Metastatic Cancer

    Article • Clinical Journal of the American Society of Nephrology, March 2020, American Society of Nephrology

    Roslyn Mannon, Roslyn Mannon

  78. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale

    Article • Kidney International Reports, March 2020, Elsevier

    Roslyn Mannon

  79. Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes

    Article • Annals of Surgery, January 2020, Wolters Kluwer Health

    Roslyn Mannon

  80. Clinical Pig Kidney Xenotransplantation: How Close Are We?

    Article • Journal of the American Society of Nephrology, December 2019, American Society of Nephrology

    Roslyn Mannon

  81. The effect of renal transplantation on left ventricular function, electrocardiography, and mechanical synchrony by gated myocardial perfusion imaging

    Article • Journal of Nuclear Cardiology, December 2019, Elsevier

    Roslyn Mannon

  82. Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial

    Article • American Journal of Transplantation, October 2019, Elsevier

    Roslyn Mannon

  83. Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups

    Article • American Journal of Transplantation, October 2019, Elsevier

    Roslyn Mannon

  84. WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure

    Article • American Journal of Transplantation, October 2019, Elsevier

    Roslyn Mannon

  85. Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A

    Article • Transplantation, August 2019, Wolters Kluwer Health

    Roslyn Mannon

  86. Letter to the Editor

    Article • Clinical Infectious Diseases, July 2019, Oxford University Press (OUP)

    Roslyn Mannon

  87. Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies

    Article • Transplantation, June 2019, Wolters Kluwer Health

    Roslyn Mannon

  88. CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients

    Article • Pediatric Transplantation, May 2019, Wiley

    Roslyn Mannon

  89. Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNA

    Article • American Journal of Transplantation, May 2019, Elsevier

    Roslyn Mannon

  90. Long-term follow-up of the DeKAF cross-sectional cohort study

    Article • American Journal of Transplantation, May 2019, Elsevier

    Roslyn Mannon

  91. Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function

    Article • Transplantation Proceedings, April 2019, Elsevier

    Roslyn Mannon

  92. Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice

    Article • Transplantation Proceedings, April 2019, Elsevier

    Roslyn Mannon

  93. The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population

    Article • American Journal of Transplantation, March 2019, Wiley

    Prof Alexander P Maxwell, Roslyn Mannon

  94. The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium’s position statement

    Article • American Journal of Transplantation, March 2019, Elsevier

    Roslyn Mannon

  95. Post-Transplant Lymphoproliferative Disorder in a Kidney Transplant Recipient

    Article • Clinical Journal of the American Society of Nephrology, February 2019, American Society of Nephrology

    Roslyn Mannon, Roslyn Mannon

  96. Acute Kidney Injury in Kidney Transplants: New Insights

    Article • January 2019, Karger Publishers

    Roslyn Mannon

  97. The Banff schema for antibody-mediated rejection: Lost in translation?

    Article • American Journal of Transplantation, January 2019, Elsevier

    Roslyn Mannon

  98. Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop

    Article • Kidney International, December 2018, Elsevier

    Dr Tushar Vachharajani , Professor Albert Ong, Roslyn Mannon

  99. Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing

    Article • The Pharmacogenomics Journal, November 2018, Springer Science + Business Media

    Roslyn Mannon

  100. Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients

    Article • Clinical Transplantation, October 2018, Wiley

    Casey Dorr, Roslyn Mannon

  101. Meeting report of the STAR—Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation

    Article • American Journal of Transplantation, September 2018, Elsevier

    Roslyn Mannon

  102. Author Correction: Metformin reverses established lung fibrosis in a bleomycin model

    Article • Nature Reports Stem Cells, August 2018, Springer Science + Business Media

    Roslyn Mannon

  103. Establishing a Core Outcome Measure for Graft Health

    Article • Transplantation, August 2018, Wolters Kluwer Health

    Roslyn Mannon

  104. Thrombotic Microangiopathy in a Transplant Recipient

    Article • Clinical Journal of the American Society of Nephrology, July 2018, Wolters Kluwer Health

    Roslyn Mannon, Roslyn Mannon

  105. Metformin reverses established lung fibrosis in a bleomycin model

    Article • Nature Reports Stem Cells, July 2018, Springer Science + Business Media

    Roslyn Mannon

  106. Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation

    Article • American Journal of Transplantation, June 2018, Wiley

    Roslyn Mannon

  107. Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors

    Article • Annals of Surgery, June 2018, Wolters Kluwer Health

    Roslyn Mannon

  108. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report

    Article • American Journal of Transplantation, May 2018, Wiley

    Steve Woodle, Roslyn Mannon

  109. Late graft failure after kidney transplantation as the consequence of late versus early events

    Article • American Journal of Transplantation, May 2018, Elsevier

    Roslyn Mannon

  110. NPHP1(Nephrocystin-1) Gene Deletions Cause Adult-Onset ESRD

    Article • Journal of the American Society of Nephrology, April 2018, American Society of Nephrology

    Roslyn Mannon

  111. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

    Article • American Journal of Transplantation, January 2018, Wiley

    Roslyn Mannon

  112. Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients

    Article • Pharmacogenomics, January 2018, Future Medicine

    Roslyn Mannon

  113. Delayed Graft Function: The AKI of Kidney Transplantation

    Article • January 2018, Karger Publishers

    Roslyn Mannon

  114. Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients

    Article • The Pharmacogenomics Journal, November 2017, Springer Science + Business Media

    Roslyn Mannon

  115. Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept

    Article • American Journal of Transplantation, July 2017, Wiley

    Roslyn Mannon

  116. Clinical Trials for Immunosuppression in Transplantation

    Article • Transplantation, July 2017, Wolters Kluwer Health

    Roslyn Mannon

  117. Effect of a Mobile Web App on Kidney Transplant Candidates' Knowledge About Increased Risk Donor Kidneys

    Article • Transplantation, June 2017, Wolters Kluwer Health

    Roslyn Mannon

  118. Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study

    Article • American Journal of Transplantation, May 2017, Wiley

    Roslyn Mannon, Roslyn Mannon

  119. B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function

    Article • American Journal of Transplantation, May 2017, Wiley

    Roslyn Mannon

  120. Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications

    Article • The Journal of Applied Laboratory Medicine, March 2017, AACC

    Daniel C Brennan, Roslyn Mannon, Roslyn Mannon

  121. Cell-Free DNA and Active Rejection in Kidney Allografts

    Article • Journal of the American Society of Nephrology, March 2017, American Society of Nephrology

    Roslyn Mannon

  122. Obesity increases the risk of end-stage renal disease among living kidney donors

    Article • Kidney International, March 2017, Elsevier

    Roslyn Mannon

  123. Access to Kidney Transplantation among HIV-Infected Waitlist Candidates

    Article • Clinical Journal of the American Society of Nephrology, February 2017, American Society of Nephrology

    Roslyn Mannon

  124. Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis

    Article • Clinical Infectious Diseases, May 2016, Oxford University Press (OUP)

    Roslyn Mannon

  125. Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward

    Article • American Journal of Transplantation, April 2016, Elsevier

    Roslyn Mannon

  126. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation

    Article • Transplantation, January 2016, Wolters Kluwer Health

    Roslyn Mannon

  127. Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

    Article • The Pharmacogenomics Journal, December 2015, Springer Science + Business Media

    Roslyn Mannon

  128. Hospital-Onset Clostridium difficile Infection Among Solid Organ Transplant Recipients

    Article • American Journal of Transplantation, November 2015, Elsevier

    Roslyn Mannon

  129. Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies MultipleCYP3A5Alleles

    Article • American Journal of Transplantation, October 2015, Wiley

    Roslyn Mannon

  130. Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients

    Article • American Journal of Transplantation, August 2015, Elsevier

    Roslyn Mannon

  131. Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine

    Article • Transplantation Reviews, April 2015, Elsevier

    Roslyn Mannon

  132. The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable?

    Article • Current Transplantation Reports, March 2015, Springer Science + Business Media

    Roslyn Mannon

  133. Identification of Strategies to Facilitate Organ Donation among African Americans using the Nominal Group Technique

    Article • Clinical Journal of the American Society of Nephrology, January 2015, American Society of Nephrology

    Roslyn Mannon, Roslyn Mannon

  134. Cyclosporine-mediated allograft fibrosis is associated with micro-RNA-21 through AKT signaling

    Article • Transplant International, October 2014, Wiley

    Roslyn Mannon, Roslyn Mannon

  135. The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease

    Article • Journal of Nuclear Cardiology, August 2014, Elsevier

    Roslyn Mannon

  136. Mitigation of Racial Disparities After Simultaneous Pancreas and Kidney Transplantation.

    Article • Transplantation, July 2014, Wolters Kluwer Health

    Roslyn Mannon

  137. The Microbiota, the Immune System and the Allograft

    Article • American Journal of Transplantation, May 2014, Wiley

    Maria-Luisa Alegre, Roslyn Mannon

  138. Immunosuppression Regimen and the Risk of Acute Rejection in HIV-Infected Kidney Transplant Recipients

    Article • Transplantation, February 2014, Wolters Kluwer Health

    Roslyn Mannon

  139. Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions

    Article • American Journal of Transplantation, February 2014, Elsevier

    Mark Haas, Roslyn Mannon

  140. Necroptosis in Solid Organ Transplantation: A Missing Link to Immune Activation?

    Article • American Journal of Transplantation, November 2013, Elsevier

    Roslyn Mannon

  141. Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma

    Article • Transplant International, July 2013, Frontiers

    Roslyn Mannon

  142. Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling

    Article • American Journal of Transplantation, July 2013, Elsevier

    Roslyn Mannon

  143. A reproducible mouse model of chronic allograft nephropathy with vasculopathy

    Article • Kidney International, December 2012, Elsevier

    Roslyn Mannon

  144. Associations of ABCB1 and IL-10 Genetic Polymorphisms With Sirolimus-Induced Dyslipidemia in Renal Transplant Recipients

    Article • Transplantation, November 2012, Wolters Kluwer Health

    Roslyn Mannon

  145. A Case of Late Kidney Allograft Failure: A Clinical Pathological Conference from American Society of Nephrology Kidney Week 2011

    Article • Clinical Journal of the American Society of Nephrology, August 2012, American Society of Nephrology

    Roslyn Mannon, Roslyn Mannon

  146. Reply to “Genetic Determinants of Mycophenolate-Related Anemia and Leukopenia After Transplantation”

    Article • Transplantation, May 2012, Wolters Kluwer Health

    Roslyn Mannon

  147. Macrophages

    Article • Current Opinion in Organ Transplantation, February 2012, Wolters Kluwer Health

    Roslyn Mannon

  148. Associations of ABCB1 3435C>T and IL-10-1082G>A Polymorphisms With Long-Term Sirolimus Dose Requirements in Renal Transplant Patients

    Article • Transplantation, December 2011, Wolters Kluwer Health

    Roslyn Mannon

  149. What’s New, What’s Hot in Solid Organ Transplantation? Summary of the American Transplant Congress 2011

    Article • American Journal of Transplantation, November 2011, Elsevier

    Roslyn Mannon

  150. Elevated expression levels of ANXA11, integrins β3 and α3, and TNF‐α contribute to a candidate proteomic signature in urine for kidney allograft rejection

    Article • PROTEOMICS - CLINICAL APPLICATIONS, May 2011, Wiley

    Roslyn Mannon

  151. Genetic Determinants of Mycophenolate-Related Anemia and Leukopenia After Transplantation

    Article • Transplantation, February 2011, Wolters Kluwer Health

    Roslyn Mannon

  152. Novel Polymorphisms Associated With Tacrolimus Trough Concentrations: Results From a Multicenter Kidney Transplant Consortium

    Article • Transplantation, February 2011, Wolters Kluwer Health

    Roslyn Mannon

  153. Chemokines and Their Receptors in Human Renal Allotransplantation

    Article • Transplantation, January 2011, Wolters Kluwer Health

    Roslyn Mannon

  154. Lack of Renal Dopamine D5 Receptors Promotes Hypertension

    Article • Journal of the American Society of Nephrology, January 2011, Wolters Kluwer Health

    Roslyn Mannon

  155. Immune monitoring and biomarkers to predict chronic allograft dysfunction

    Article • Kidney International, December 2010, Elsevier

    Roslyn Mannon

  156. Optimal Cutoff Point for Immunoperoxidase Detection of C4d in the Renal Allograft: Results From a Multicenter Study

    Article • Transplantation, November 2010, Wolters Kluwer Health

    Roslyn Mannon

  157. Cinacalcet Improves Bone Density in Post–Kidney Transplant Hyperparathyroidism

    Article • Transplantation Proceedings, November 2010, Elsevier

    Roslyn Mannon

  158. Inflammation in Areas of Tubular Atrophy in Kidney Allograft Biopsies: A Potent Predictor of Allograft Failure

    Article • American Journal of Transplantation, September 2010, Elsevier

    Roslyn Mannon

  159. Probabilistic (Bayesian) Modeling of Gene Expression in Transplant Glomerulopathy

    Article • Journal of Molecular Diagnostics, September 2010, Elsevier

    Roslyn Mannon

  160. Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure

    Article • Transplantation, July 2010, Wolters Kluwer Health

    Roslyn Mannon

  161. Evaluation of tacrolimus abbreviated area‐under‐the‐curve monitoring in renal transplant patients who are potientially at risk for adverse events

    Article • Clinical Transplantation, July 2010, Wiley

    Roslyn Mannon

  162. Low-density array PCR analysis of reperfusion biopsies: an adjunct to histological analysis

    Article • Nephrology Dialysis Transplantation, May 2010, Oxford University Press (OUP)

    Roslyn Mannon

  163. Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

    Article • American Journal of Transplantation, March 2010, Elsevier

    Roslyn Mannon

  164. Allograft Fibrosis—Unmasking the Players at the Dance

    Article • American Journal of Transplantation, February 2010, Elsevier

    Roslyn Mannon

  165. Histopathologic Clusters Differentiate Subgroups Within the Nonspecific Diagnoses of CAN or CR: Preliminary Data from the DeKAF Study

    Article • American Journal of Transplantation, February 2010, Elsevier

    Roslyn Mannon

  166. Pathological and Clinical Characterization of the ‘Troubled Transplant’: Data from the DeKAF Study

    Article • American Journal of Transplantation, February 2010, Elsevier

    Roslyn Mannon

  167. Noninvasive methods to assess the risk of kidney transplant rejection

    Article • Expert Review of Clinical Immunology, September 2009, Taylor & Francis

    Roslyn Mannon

  168. C3 Polymorphisms and Outcomes of Renal Allografts

    Article • New England Journal of Medicine, June 2009, New England Journal of Medicine (NEJM/MMS)

    Roslyn Mannon

  169. Post-transplantation Monitoring and Outcomes

    Article • January 2009, Elsevier

    Roslyn Mannon

  170. Islet transplantation: need for a time-out?

    Article • Nature Clinical Practice Nephrology, September 2008, Springer Science + Business Media

    Roslyn Mannon

  171. Lymphocyte depletion for kidney transplantation: back to the past?

    Article • Nature Clinical Practice Nephrology, August 2008, Springer Science + Business Media

    Roslyn Mannon

  172. Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients

    Article • American Journal of Transplantation, June 2008, Elsevier

    Roslyn Mannon

  173. Leflunomide Therapy in Kidney Transplantation

    Article • Clinical Journal of the American Society of Nephrology, May 2008, Wolters Kluwer Health

    Roslyn Mannon

  174. Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions

    Article • American Journal of Transplantation, April 2008, Elsevier

    Roslyn Mannon

  175. Therapeutic management of posttransplant diabetes mellitus

    Article • Transplantation Reviews, April 2008, Elsevier

    Roslyn Mannon

  176. Care of the Kidney Transplant Recipient

    Article • Clinical Journal of the American Society of Nephrology, March 2008, Wolters Kluwer Health

    Roslyn Mannon

  177. Late Kidney Allograft Loss

    Article • Clinical Journal of the American Society of Nephrology, March 2008, Wolters Kluwer Health

    Roslyn Mannon

  178. Monocyte Infiltration and Kidney Allograft Dysfunction During Acute Rejection

    Article • American Journal of Transplantation, March 2008, Elsevier

    Roslyn Mannon

  179. Obesity following kidney transplantation and steroid avoidance immunosuppression

    Article • Clinical Transplantation, February 2008, Wiley

    Roslyn Mannon

  180. Diagnostic Tools for Monitoring Kidney Transplant Recipients

    Article • Seminars in Nephrology, July 2007, Elsevier

    Roslyn Mannon

  181. Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)

    Article • American Journal of Transplantation, March 2007, Elsevier

    Roslyn Mannon

  182. Immunodiagnostics: Evaluation of Functional T-Cell Immunocompetence in Whole Blood Independent of Circulating Cell Numbers

    Article • Journal of Immunotoxicology, January 2007, Taylor & Francis

    Roslyn Mannon

  183. Connective Tissue Growth Factor is a Biomarker and Mediator of Kidney Allograft Fibrosis

    Article • American Journal of Transplantation, October 2006, Elsevier

    Roslyn Mannon

  184. Assessing Relative Risks of Infection and Rejection: A Meta-analysis using an Immune Function Assay

    Article • Transplantation, September 2006, Wolters Kluwer Health

    Roslyn Mannon

  185. Autoimmune Thyroid Disease After Renal Transplantation Using Depletional Induction with Alemtuzumab

    Article • American Journal of Transplantation, May 2006, Elsevier

    Roslyn Mannon

  186. Beyond Histology

    Article • Clinical Journal of the American Society of Nephrology, May 2006, Wolters Kluwer Health

    Roslyn Mannon

  187. Therapeutic Targets in the Treatment of Allograft Fibrosis

    Article • American Journal of Transplantation, May 2006, Elsevier

    Roslyn Mannon

  188. Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154

    Article • Journal of Clinical Investigation, March 2006, American Society for Clinical Investigation

    Roslyn Mannon

  189. Successful Renal Transplantation in Patients with Chronic Granulomatous Disease

    Article • American Journal of Transplantation, March 2006, Elsevier

    Roslyn Mannon

  190. Molecular Evaluation of BK Polyomavirus Nephropathy

    Article • American Journal of Transplantation, December 2005, Elsevier

    Roslyn Mannon

  191. Results from a Human Renal Allograft Tolerance Trial Evaluating T-Cell Depletion with Alemtuzumab Combined with Deoxyspergualin

    Article • Transplantation, October 2005, Wolters Kluwer Health

    Roslyn Mannon

  192. Idiopathic intracranial hypertension following kidney transplantation: A case report and review of the literature

    Article • Pediatric Transplantation, August 2005, Wiley

    Chief, Neuroradiology Section John A Butman, Roslyn Mannon

  193. Detection and Localization of Proteinuria by Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using MS325

    Article • Journal of the American Society of Nephrology, June 2005, Wolters Kluwer Health

    Roslyn Mannon

  194. Surgical transplant physical examination: Correlation of renal resistance index and biopsy-proven chronic allograft nephropathy

    Article • Journal of the American College of Surgeons, April 2005, Wolters Kluwer Health

    Roslyn Mannon

  195. Functionally Significant Renal Allograft Rejection Is Defined by Transcriptional Criteria

    Article • American Journal of Transplantation, March 2005, Elsevier

    Roslyn Mannon

  196. Immunocompetent T-Cells with a Memory-Like Phenotype are the Dominant Cell Type Following Antibody-Mediated T-Cell Depletion

    Article • American Journal of Transplantation, March 2005, Elsevier

    Roslyn Mannon

  197. First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future

    Article • Pediatric Nephrology, January 2005, Springer Science + Business Media

    Roslyn Mannon

  198. Strategies for minimizing immunosuppression in kidney transplantation

    Article • Transplant International, January 2005, Frontiers

    Roslyn Mannon

  199. Donor genomics influence graft events: The effect of donor polymorphisms on acute rejection and chronic allograft nephropathy

    Article • Kidney International, October 2004, Elsevier

    Roslyn Mannon

  200. The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials

    Article • Transplant Immunology, September 2004, Elsevier

    Roslyn Mannon

  201. POLYOMAVIRUS NEPHROPATHY: WHAT HAVE WE LEARNED?1

    Article • Transplantation, May 2004, Wolters Kluwer Health

    Roslyn Mannon

  202. The clinical application of monoclonal antibody therapies in renal transplantation

    Article • Expert Opinion on Emerging Drugs, May 2004, Taylor & Francis

    Roslyn Mannon

  203. Successful Renal Transplantation in a Patient with Congenital Generalized Lipodystrophy: A Case Report

    Article • American Journal of Transplantation, March 2004, Elsevier

    Roslyn Mannon

  204. Immunologic monitoring of the transplant recipient: challenges and approaches with antibody induction

    Article • Transplantation Reviews, October 2003, Elsevier

    Roslyn Mannon

  205. RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)

    Article • Transplantation, July 2003, Wolters Kluwer Health

    Roslyn Mannon

  206. Delayed autotransplantation of a solitary kidney facilitated by pump perfusion preservation

    Article • Surgery, April 2003, Elsevier

    Roslyn Mannon

  207. Inhibition of Prolyl-4-Hydroxylase Ameliorates Chronic Rejection of Mouse Kidney Allografts

    Article • American Journal of Transplantation, April 2003, Elsevier

    Roslyn Mannon

  208. Kidney transplantation with rabbit antithymocyte globulin and sirolimus monotherapy

    Article • The Lancet, March 2003, Elsevier

    Roslyn Mannon

  209. BK virus and SV40 co-infection in polyomavirus nehropathy1

    Article • Transplantation, December 2002, Wolters Kluwer Health

    Roslyn Mannon

  210. Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

    Article • The Lancet, November 2002, Elsevier

    Roslyn Mannon

  211. Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury

    Article • Transplantation, October 2002, Wolters Kluwer Health

    Roslyn Mannon

  212. Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection

    Article • Kidney International, July 2002, Elsevier

    Roslyn Mannon

  213. Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice

    Article • The Journal of Immunology, December 2001, The American Association of Immunologists

    Roslyn Mannon

  214. Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse

    Article • Journal of Clinical Investigation, October 2001, American Society for Clinical Investigation

    Roslyn Mannon

  215. ALTERED INTRAGRAFT IMMUNE RESPONSES AND IMPROVED RENAL FUNCTION IN MHC CLASS II-DEFICIENT MOUSE KIDNEY ALLOGRAFTS12

    Article • Transplantation, May 2000, Wolters Kluwer Health

    Roslyn Mannon

  216. Stimulation of Thymocyte Proliferation by Phosphorothioate DNA Oligonucleotides

    Article • Cellular Immunology, April 2000, Elsevier

    Roslyn Mannon

  217. ENHANCED T CELL CYTOKINE GENE EXPRESSION IN MOUSE AIRWAY OBLITERATIVE BRONCHIOLITIS1

    Article • Transplantation, February 2000, Wolters Kluwer Health

    Roslyn Mannon

  218. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway

    Article • Journal of Clinical Investigation, December 1999, American Society for Clinical Investigation

    Roslyn Mannon

  219. Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection

    Article • The Journal of Heart and Lung Transplantation, September 1999, Elsevier

    Roslyn Mannon

  220. Peptide YY/neuropeptide Y Y1 receptor expression in the epithelium and mucosal nerves of the human colon

    Article • Regulatory Peptides, August 1999, Elsevier

    Roslyn Mannon

  221. Gene targeting: Applications in transplantation research

    Article • Kidney International, July 1999, Elsevier

    Roslyn Mannon

  222. Chronic rejection of mouse kidney allografts

    Article • Kidney International, May 1999, Elsevier

    Roslyn Mannon

  223. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.

    Article • Journal of Clinical Investigation, December 1998, American Society for Clinical Investigation

    Roslyn Mannon

  224. Immune Cells in a Mouse Airway Model of Obliterative Bronchiolitis

    Article • American Journal of Respiratory Cell and Molecular Biology, September 1998, American Thoracic Society

    Roslyn Mannon

  225. Thromboxane A2modulates the fibrinolytic system in glomerular mesangial cells

    Article • AJP Renal Physiology, August 1998, American Physiological Society

    Roslyn Mannon

  226. Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts.

    Article • Journal of Clinical Investigation, June 1998, American Society for Clinical Investigation

    Roslyn Mannon

  227. Distribution of binding sites for thromboxane A2 in the mouse kidney

    Article • AJP Renal Physiology, December 1996, American Physiological Society

    Roslyn Mannon

  228. THE INTRAGRAFT CD8+ T CELL RESPONSE IN RENAL ALLOGRAFT REJECTION IN THE MOUSE1,2

    Article • Transplantation, July 1996, Wolters Kluwer Health

    Roslyn Mannon

  229. REJECTION OF KIDNEY ALLOGRAFTS BY MHC CLASS I-DEFICIENT MICE

    Article • Transplantation, March 1995, Wolters Kluwer Health

    Roslyn Mannon

  230. Hyperrenin-Hyperaldosterone-Dependent Malignant Hypertension in Polyarteritis Nodosa

    Article • Southern Medical Journal, December 1993, Southern Medical Association

    Roslyn Mannon

  231. Alterations In Renal Interleukin-1 Production During Kidney Transplant Rejection In The Rat

    Article • Transplantation, November 1993, Wolters Kluwer Health

    Roslyn Mannon

  232. Immunologic mechanisms of transplant rejection

    Article • Current Opinion in Nephrology & Hypertension, December 1992, Wolters Kluwer Health

    Roslyn Mannon

  233. Myocardial ischemia in constrictive pericarditis

    Article • American Heart Journal, October 1988, Elsevier

    Roslyn Mannon

  234. Role of immune stimulation in the etiology of multiple myeloma: A case control study

    Article • American Journal of Hematology, February 1987, Wiley

    Roslyn Mannon

  235. A plasma membrane factor inhibiting intercellular adhesion in Polysphondylium pallidum

    Article • Cell Differentiation, February 1983, Elsevier

    Roslyn Mannon